ES358265A2 - Oral compositions for calculus retardation - Google Patents

Oral compositions for calculus retardation

Info

Publication number
ES358265A2
ES358265A2 ES358265A ES358265A ES358265A2 ES 358265 A2 ES358265 A2 ES 358265A2 ES 358265 A ES358265 A ES 358265A ES 358265 A ES358265 A ES 358265A ES 358265 A2 ES358265 A2 ES 358265A2
Authority
ES
Spain
Prior art keywords
oral compositions
cooh
benzyl
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES358265A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of ES358265A2 publication Critical patent/ES358265A2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Casting Devices For Molds (AREA)

Abstract

An oral composition for inhibiting the formation of dental calculus comprises from 0.01-10% by weight of a polyphosphonate having one of the general formulae:- wherein R 1 and R 2 are H or CH 2 OH n is 3-10 R 3 is H, C 1 -C 20 alkyl, C 2 -C 20 akenyl, aryl, benzyl, phenylethenyl, halogen, -OH, -NH 2 , substituted amino, -CH 2 COOH, -CH 2 PO 3 H 2 , -CH(PO 3 H 2 )OH or -CH 2 CH(PO 3 H 2 ) 2 R 4 is H, C 1 -C 4 alkyl, -NH 2 , benzyl, halogen, -OH, -CH 2 COOH, -CH 2 PO 3 H 2 , or -CH 2 CH 2 PO 3 H 2 provided that when R 3 is -OH R 4 is not CH 3 or a pharmaceutically acceptable non-toxic salt thereof or mixtures thereof in admixture with a carrier, other than water alone, suitable for use in the oral cavity, the pH of the composition being from 5-11. The compositions are suitably in the form of pastes or mouthwashes.
ES358265A 1965-12-08 1968-09-18 Oral compositions for calculus retardation Expired ES358265A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51254865A 1965-12-08 1965-12-08
US66870267A 1967-09-18 1967-09-18
US69371367A 1967-12-27 1967-12-27
US73131268A 1968-05-22 1968-05-22

Publications (1)

Publication Number Publication Date
ES358265A2 true ES358265A2 (en) 1970-06-01

Family

ID=27504505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES358265A Expired ES358265A2 (en) 1965-12-08 1968-09-18 Oral compositions for calculus retardation

Country Status (12)

Country Link
JP (1) JPS4927339B1 (en)
AT (1) AT294318B (en)
CH (1) CH524371A (en)
DE (1) DE1792506A1 (en)
DK (1) DK122031B (en)
ES (1) ES358265A2 (en)
FI (1) FI48802C (en)
FR (1) FR8154M (en)
GB (1) GB1201984A (en)
IT (1) IT1048953B (en)
NO (1) NO125914B (en)
SE (1) SE350402B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478761A (en) * 1980-04-28 1984-10-23 University Of Iowa Research Foundation Method for preparing fluorine-containing phosphonates
JPS60245426A (en) * 1984-05-18 1985-12-05 関西電力株式会社 Arrester
FI83421C (en) * 1989-06-21 1991-07-10 Huhtamaeki Oy Process for the preparation of pharmacologically useful methylene bisphosphonic acid derivatives
CA2057822C (en) * 1990-12-18 1998-04-21 Keith Philip Davis Water treatment agent
AU2001221607A1 (en) 2000-11-20 2002-05-27 Ecole Polytechnique Federale De Lausanne (Epfl) Endosseous implant

Also Published As

Publication number Publication date
IT1048953B (en) 1980-12-20
JPS4927339B1 (en) 1974-07-17
SE350402B (en) 1972-10-30
GB1201984A (en) 1970-08-12
DK122031B (en) 1972-01-10
FI48802C (en) 1975-01-10
FI48802B (en) 1974-09-30
NO125914B (en) 1972-11-27
CH524371A (en) 1972-06-30
AT294318B (en) 1971-11-25
DE1792506A1 (en) 1971-11-18
FR8154M (en) 1970-08-17

Similar Documents

Publication Publication Date Title
GB1263934A (en) Oral compositions for calculus retardation
FR2299023A1 (en) AMINOACID COMPOSITIONS
ES462062A1 (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
ES474047A1 (en) Bait compositions for anthropophilic flies
FR2326458A1 (en) COMPOSITIONS FOR COATINGS HARDENABLE, ESPECIALLY UNDER THE EFFECT OF RADIATION
IT1064927B (en) WATER DISPERSIONS OF OLEPHINE RESIN COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION
ES452764A1 (en) PROCEDURE FOR THE PREPARATION OF NEW 2-TETRAHIDROFUR-FURIL-6, 7-BENZOMORPHANES DISUSTITUTED IN 5,9-BETA.
ES454162A1 (en) Compositions containing new indole derivatives and their use in pharmacology
FR2281462A1 (en) PROTECTION AGAINST SHORELINE EROSION
JPS5412372A (en) Thiazolidine derivative and its preparation
JPS5329936A (en) Antibiotic composition
ES449963A2 (en) 5-O-Cyanobenzyl-4,5,6,7-tetrahydro-thieno{8 3,2-c{9 pyridine maleate
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
ES358265A2 (en) Oral compositions for calculus retardation
SE7708553L (en) ANTIBACTERIAL ORAL COMPOSITION
ES450897A1 (en) N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic compositions and methods employing them
ES466850A1 (en) 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension
JPS52136118A (en) Modification of bestatin and analogous compounds and their preparation
BE844909A (en) NEW FUNGICIDE COMPOSITIONS CONTAINING 1,2,4-TRIAZOLIC DERIVATIVES AND GIBBERELLINS
IT1057359B (en) IMPROVEMENT IN COMPOSITIONS FOR DENTAL USE
JPS5228507A (en) Detergent composition
JPS5217465A (en) Preparation of 4-iodo-5-bromoindole-3- phosphates
JPS5416493A (en) Novel josamycin derivatives, their salts, and their preparation
IT1069598B (en) IMPROVEMENT IN WELDING STOP COMPOSITIONS
JPS5233948A (en) Polyurethane compositions having mproved whiteness retention